Intravenous ketamine for rapid treatment of major depressive disorder in the general medical hospital

BMJ Case Rep. 2021 Oct 13;14(10):e239587. doi: 10.1136/bcr-2020-239587.

ABSTRACT

Major depressive disorder (MDD) is common in general medical settings, and can usually be treated with conventional oral antidepressants. For some patients, however, oral treatment is refused or not possible, and the untreated symptoms can have a significant impact on the treatment of the acute medical problem. Use of intravenous ketamine has been widely reported in mental health settings for the treatment of MDD. We describe use of intravenous ketamine in a general medical hospital for the treatment of MDD in an 83-year-old male patient who refused food, fluid and medical investigations following a stroke.

PMID:34645623 | DOI:10.1136/bcr-2020-239587